Bab 667: Chapter 374: Wishing You Success, Keep Going! _3

This is the lab's drug cost.

Market sales need to take into account R&D costs, profits, etc., so it's easy for the price to increase several times or even dozens of times, making it unaffordable for ordinary people.

Pharmaceutical companies have an even bigger concern.

Once the drug officially enters the market, the ingredients will be made public, and imitations will soon emerge. Some international pharmaceutical companies have stronger R&D capabilities, and they may even be able to mass-produce the 2CV-Bing Hydrogen Molecule method — entering the market would only give the others a leg up.

After Yan Xuelin explained the encountered issues, the first one to speak was Li Ming who had worked on a biochemical project and had some related experience. He drew a line on the R&D saying, "Artificial synthesis is not possible, at least not in a short time. We still have to look for biological methods for our research."